Evidence map›Paper›PMID 32970153›Full record

ArticleJAMA network open2020

Trends in Use and Comparison of Stereotactic Body Radiation Therapy, Brachytherapy, and Dose-Escalated External Beam Radiation Therapy for the Management of Localized, Intermediate-Risk Prostate Cancer.

Kevin A Nguyen, Alan Lee, Sagar A Patel, Arun Chakravorty, James B Yu, Amar U Kishan, Albert J Chang

Abstract readComparative Study
PubMed Full text at PMC Publisher
In one paragraph

Article in JAMA network open, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Kevin A NguyenDepartment of Radiation Oncology, David Geffen School of Medicine, University of California, Los Angeles.
Alan LeeDepartment of Radiation Oncology, David Geffen School of Medicine, University of California, Los Angeles.
Sagar A PatelDepartment of Radiation Oncology, Emory University, Atlanta, Georgia.
Arun ChakravortyDepartment of Radiation Oncology, David Geffen School of Medicine, University of California, Los Angeles.
James B YuDeparment of Radiation Oncology, Yale School of Medicine, New Haven, Connecticut.
Amar U KishanDepartment of Radiation Oncology, David Geffen School of Medicine, University of California, Los Angeles.
Albert J ChangDepartment of Radiation Oncology, David Geffen School of Medicine, University of California, Los Angeles.

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
NCATS NIH HHS UL1 TR001863
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AgedBrachytherapyHumansKallikreinsMaleMiddle AgedNeoplasm GradingNeoplasm StagingProportional Hazards ModelsProstate-Specific AntigenProstatic NeoplasmsRadiosurgeryRadiotherapyRadiotherapy DosageRiskSurvival RateKallikreinsKLK3 protein, humanProstate-Specific Antigen

Identifiers

PMID32970153
PMCPMC7516602

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.